⚠ You're viewing a report from September 2021. Subscribe to get the latest →

FDA Enforcement — September 2021 Report

Automated analysis of 45 items from public government data sources. Updated daily.

Summary

45
Total items
36
High impact
9
Medium impact
0
Low impact

High-impact items this period

GuangZhou YouXing Cosmetic Co., Ltd
Unapproved pharmaceutical with CGMP violations
Why: Manufacturing and distributing unapproved drugs without proper quality controls  ·  Sep 30  ·  Impact: HIGH
Marcus Research Laboratory, Inc.
Active pharmaceutical ingredient adulteration
Why: CGMP violations in API manufacturing process  ·  Sep 30  ·  Impact: HIGH
Missouri Analytical Laboratories Inc
Active pharmaceutical ingredient adulteration
Why: CGMP violations in API manufacturing process  ·  Sep 30  ·  Impact: HIGH
RAAS Nutritionals, LLC/Rare Antibody Antigen Supply, Inc.
Institutional review board compliance failure
Why: Inadequate IRB oversight of bioresearch activities  ·  Sep 30  ·  Impact: HIGH
Limpo Quimicos, SA de CV
CGMP violations, unapproved drug, misbranded, adulterated
Why: Manufacturing deficiencies and unauthorized distribution of pharmaceuticals  ·  Sep 30  ·  Impact: HIGH
HealthMEDS Inc.
Failure to permit FDA access to records
Why: Obstructed FDA inspection or record access rights  ·  Sep 29  ·  Impact: HIGH
Healthy Foods & Nutrition Lab de Mexico S.A. de C.V.
Unapproved new drug products marketed with misbranded claims
Why: Distribution of unapproved pharmaceutical products without regulatory approval  ·  Sep 29  ·  Impact: HIGH
Strategia Project Management, Inc.
Unapproved COVID-19 drug product distribution
Why: Selling unapproved coronavirus treatment products  ·  Sep 28  ·  Impact: HIGH
Chameleon Beverage Co. Inc. dba Chameleon Sanitizer Corporation
Pharmaceutical CGMP violation with adulterated finished product
Why: Manufacturing practice deviations in finished pharmaceutical preparation  ·  Sep 24  ·  Impact: HIGH
Supplement Science Corp. d/b/a Condemned Labz
Unapproved new drug products marketed with misbranded claims
Why: Selling supplements marketed as unapproved drugs without proper authorization  ·  Sep 22  ·  Impact: HIGH

Selected medium-impact items

True Chemical Solutions, LLC
Failure to permit FDA access to records and data
Why: Non-compliance with regulatory record inspection and copying requirements  ·  Sep 29  ·  Impact: MEDIUM
Kings of Vapor
Tobacco product adulteration and misbranding violations
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act  ·  Sep 27  ·  Impact: MEDIUM
The Camel Milk Co. LLC dba Camel Culture
Misbranded product marketed as new drug
Why: Making therapeutic claims without approval as drug product  ·  Sep 22  ·  Impact: MEDIUM
Dulces La Mejor, LLC
Foreign supplier verification program violations for food imports
Why: Inadequate foreign supplier verification and food safety procedures  ·  Sep 15  ·  Impact: MEDIUM
Selected Food & Beverage, Inc.
Foreign supplier verification program non-compliance
Why: Inadequate verification procedures for foreign food suppliers  ·  Sep 07  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →